ZyVersa Therapeutics Inc.

1.10
-0.03 (-2.65%)
At close: Mar 03, 2025, 11:04 AM

ZyVersa Therapeutics Ratios Statement

Year FY23 FY22 FY21 FY20
PE Ratio -0.01 -0.02 -18 -12.15
PEG Ratio -0.00 -0.00 0.50 n/a
PS Ratio n/a n/a n/a n/a
PB Ratio 0.08 0.14 -12.83 -18.73
P/FCF Ratio -0.1 -9.53 -31.58 -31.38
P/OCF Ratio -0.1 -9.53 -31.58 -31.38
OCF/S Ratio n/a n/a n/a n/a
Debt / Equity Ratio 0.00 0.00 -0.73 -0.45
Quick Ratio 0.33 0.78 0.06 0.04
Current Ratio 0.33 0.78 0.06 0.04
Asset Turnover n/a n/a n/a n/a
Interest Coverage 31.56 -30.44 -9.38 -22.91
Return on Equity (ROE) -8.88 -7.59 0.71 1.54
Return on Assets (ROA) -4.44 -6.41 -7.91 -19.25
Return on Capital (ROIC) -1.21 -0.12 0.62 1.72
Dividend Yield n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a